There is skepticism among cardiologists whether flat panel detectors can help lower the X-ray dose more than using traditional image intensifiers in the cath lab. There was a story concerning this in the last issue of DAIC which said flat panel detectors are replacing image intensifiers partly because they help lower the X-ray exposure to patients.

October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.

October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting Coronary Stent System based on the product's design and strong clinical data, the next-generation drug eluting stent represents a significant advance in the treatment of coronary artery disease.

October 30, 2008 - Thoratec Corp. this week notified healthcare professionals of a worldwide correction of the HeartMate II Left Ventricular Assist System (HM II LVAS), of all serial numbers (having catalog numbers 1355 or 102139), distributed since the beginning of clinical studies in November 2003.

October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in treating fluid overload in heart failure patients were presented at the recent Heart Failure Society of America (HFSA) 2008 Annual Scientific Meeting in Toronto, Canada.

The company’s Aquapheresis therapy is a simplified method for safely and effectively removing the excess salt and water in patients with fluid overload. The company said the independent studies continue to validate the results of earlier research.

October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in-man trials were released Oct. 13 at TCT, marking an important milestone for Cappella.

October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.

October 29, 2008 - Critical Diagnostics today announced the publication of a research paper and an accompanying editorial comment further refining the clinical value and risk of mortality prediction power of the cardiac biomarker soluble ST2 (sST2).

Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported low viscosity allows it to reach distal vessels. It also has the lowest osmolality of all nonionic monomers in the U.S. Together, these properties facilitate ease of injection, help improve patient comfort and provide visualization and image quality.

Covidien's Optistar Elite contrast delivery system injects contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now